Filing Flows › Comparisons › VYCO vs PLSE
Vycor Medical vs Pulse Biosciences: VYCO and PLSE compared
Vycor Medical is the larger company: $418K of revenue in its latest quarter (Q2 2026) against $395K for Pulse Biosciences (Q3 2026). Pulse Biosciences is growing faster (+359% against -16% a year earlier).
Where the money goes: VYCO and PLSE
Vycor Medical (VYCO) · Q2 2026
Vycor Medical, Q2 2026: revenue $418K (-16% year over year), operating margin 1.6%, net loss $22K, operating cash flow −$5K. The chart follows the revenue to costs, profit and cash.
Pulse Biosciences (PLSE) · Q3 2026
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
| Vycor Medical (VYCO) | Pulse Biosciences (PLSE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $418K | $395K |
| Revenue growth, Y/Y | -16% | +359% |
| Operating margin | 1.6% | n/m |
| Net earnings | −$22K | −$23.1M |
| Net margin | -5.3% | — |
| Operating cash flow | −$5K | −$15.3M |
Where the revenue comes from
Vycor Medical
- Vycor Medical Inc: $401K (96%)
- NovaVision Inc: $17K (4%)
Questions
Which is bigger, Vycor Medical or Pulse Biosciences?
Vycor Medical is the larger company: $418K of revenue in its latest quarter (Q2 2026) against $395K for Pulse Biosciences (Q3 2026).
Is Vycor Medical or Pulse Biosciences growing faster?
Pulse Biosciences is growing faster (+359% against -16% a year earlier).
More: Vycor Medical earnings · how Vycor Medical makes money · Pulse Biosciences earnings · how Pulse Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.